Application

EVRA-CEL

Atara Biotherapeutics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97238048
Filing Date: 01/25/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97238048
MARK INFORMATION
*MARK EVRA-CEL
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT EVRA-CEL
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Atara Biotherapeutics, Inc.
*MAILING ADDRESS 611 Gateway Blvd, Suite 900
*CITY South San Francisco
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94080
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Jesse A. Salen
ATTORNEY DOCKET NUMBER 33PB-347344
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Sheppard Mullin Richter & Hampton LLP
STREET 12275 El Camino Real, Suite 100
CITY San Diego
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 92130
PHONE 858-720-8900
FAX 858-509-3961
EMAIL ADDRESS docketing@sheppardmullin.com
OTHER APPOINTED ATTORNEY David E. Heisey
CORRESPONDENCE INFORMATION
NAME Jesse A. Salen
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@sheppardmullin.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /mark kresnak/
SIGNATORY'S NAME Mark T. Kresnak, Ph.D., J.D.
SIGNATORY'S POSITION Vice President, Intellectual Property and Corporate Transactions
DATE SIGNED 01/25/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97238048
Filing Date: 01/25/2022

To the Commissioner for Trademarks:

MARK: EVRA-CEL (Standard Characters, see mark)
The literal element of the mark consists of EVRA-CEL. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Atara Biotherapeutics, Inc., a corporation of Delaware, having an address of
      611 Gateway Blvd, Suite 900
      South San Francisco, California 94080
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Jesse A. Salen. Other appointed attorneys are David E. Heisey. Jesse A. Salen of Sheppard Mullin Richter & Hampton LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      12275 El Camino Real, Suite 100
      San Diego, California 92130
      United States
      858-720-8900(phone)
      858-509-3961(fax)
      docketing@sheppardmullin.com
The docket/reference number is 33PB-347344.
Jesse A. Salen submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Jesse A. Salen
       PRIMARY EMAIL FOR CORRESPONDENCE: docketing@sheppardmullin.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /mark kresnak/   Date: 01/25/2022
Signatory's Name: Mark T. Kresnak, Ph.D., J.D.
Signatory's Position: Vice President, Intellectual Property and Corporate Transactions
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97238048
Payment Accounting Date: 01/25/2022

Serial Number: 97238048
Internet Transmission Date: Tue Jan 25 20:06:33 ET 2022
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202201252006333
42703-97238048-810c7208cad9dd73694337eb9
89ca33785e5c92cf280436d64ab7f98b6a1ec7c-
DA-06333955-20220125150719160585

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed